171 related articles for article (PubMed ID: 22333689)
41. Unique correlation between mutated citrullinated vimentine IgG autoantibodies and markers of systemic inflammation in rheumatoid arthritis patients.
Zahran WE; Mahmoud MI; Shalaby KA; Abbas MH
Indian J Clin Biochem; 2013 Jul; 28(3):272-6. PubMed ID: 24426223
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic performances of anti-cyclic citrullinated peptide antibodies type IgM, IgA and IgG in Syrian patients with rheumatoid arthritis.
Awwad HM; Aboukhamis I
Clin Lab; 2010; 56(3-4):95-102. PubMed ID: 20476640
[TBL] [Abstract][Full Text] [Related]
43. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS
Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399
[TBL] [Abstract][Full Text] [Related]
44. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.
Vallbracht I; Rieber J; Oppermann M; Förger F; Siebert U; Helmke K
Ann Rheum Dis; 2004 Sep; 63(9):1079-84. PubMed ID: 15308516
[TBL] [Abstract][Full Text] [Related]
45. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
46. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?
Girelli F; Foschi FG; Bedeschi E; Calderoni V; Stefanini GF; Martinelli MG
Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):127-30. PubMed ID: 15180353
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis.
Besada E; Nikolaisen C; Nossent H
Clin Exp Rheumatol; 2011; 29(1):85-8. PubMed ID: 21269572
[TBL] [Abstract][Full Text] [Related]
48. Antibodies to mutated citrullinated vimentin in patients with chronic hepatitis C virus genotype IV infection-related arthropathy.
Zehairy M; Soliman E; Daghaidy A
Rheumatol Int; 2012 Nov; 32(11):3495-501. PubMed ID: 22068352
[TBL] [Abstract][Full Text] [Related]
49. Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients.
García-Berrocal B; González C; Pérez M; Navajo JA; Moreta I; Dávila C; González-Buitrago JM
Clin Chim Acta; 2005 Apr; 354(1-2):123-30. PubMed ID: 15748608
[TBL] [Abstract][Full Text] [Related]
50. [Topics on immunological tests for rheumatoid arthritis].
Kumagai S; Nishimura K; Hayashi N
Rinsho Byori; 2004 Oct; 52(10):836-43. PubMed ID: 15624500
[TBL] [Abstract][Full Text] [Related]
51. Mutated citrullinated vimentin antibodies in rheumatoid arthritis.
Kuna AT
Clin Chim Acta; 2012 Jan; 413(1-2):66-73. PubMed ID: 22037509
[TBL] [Abstract][Full Text] [Related]
52. Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis.
Mutlu N; Bicakcigil M; Tasan DA; Kaya A; Yavuz S; Ozden AI
J Rheumatol; 2009 Mar; 36(3):491-500. PubMed ID: 19228660
[TBL] [Abstract][Full Text] [Related]
53. Antibodies to citrullinated peptides in tuberculosis.
Lima I; Oliveira RC; Atta A; Marchi S; Barbosa L; Reis E; Reis MG; Santiago MB
Clin Rheumatol; 2013 May; 32(5):685-7. PubMed ID: 23344687
[TBL] [Abstract][Full Text] [Related]
54. Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA).
Lipinska J; Lipinska S; Kasielski M; Smolewska E
Clin Rheumatol; 2016 Nov; 35(11):2699-2706. PubMed ID: 27457366
[TBL] [Abstract][Full Text] [Related]
55. [Significance of anti-cyclic citrullinated peptide antibody and magnetic resonance imaging of metacarpophalangeal joints and wrist in early rheumatoid arthritis].
Yue T; Cheng P; Fan XL; Sun HM; Zhou JL; He DY; Chen JH; Zhang ZM
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(23):1633-6. PubMed ID: 21914399
[TBL] [Abstract][Full Text] [Related]
56. Meta-analysis: compared with anti-CCP and rheumatoid factor, could anti-MCV be the next biomarker in the rheumatoid arthritis classification criteria?
Zhu JN; Nie LY; Lu XY; Wu HX
Clin Chem Lab Med; 2019 Oct; 57(11):1668-1679. PubMed ID: 31141478
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
[TBL] [Abstract][Full Text] [Related]
58. [Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1].
Correa PA; Tobón GJ; Citera G; Cadena J; Schneeberger E; Camargo JF; Maldonado-Cocco JA; Anaya JM
Biomedica; 2004 Jun; 24(2):140-52. PubMed ID: 15495594
[TBL] [Abstract][Full Text] [Related]
59. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.
Goëb V; Dieudé P; Daveau R; Thomas-L'otellier M; Jouen F; Hau F; Boumier P; Tron F; Gilbert D; Fardellone P; Cornélis F; Le Loët X; Vittecoq O
Rheumatology (Oxford); 2008 Aug; 47(8):1208-12. PubMed ID: 18535030
[TBL] [Abstract][Full Text] [Related]
60. [The clinical informativeness of detection of antibodies to citrullinated proteins under rheumatoid arthritis].
Cherkasova MV; Novikov AA; Alexndrova EN; Karateev DE; Popkova TV; Luchikhina EL; Avdeeva AS; Nasonov EL
Klin Lab Diagn; 2015 Feb; 60(2):46-9. PubMed ID: 26027260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
